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Abstract
Background: Sarcopenia has been associated with reduced physical activity (PA). We aimed to determine if sarcopenia, and specific components 
of muscle size, function, and physical performance, are associated with high impacts achieved during habitual PA, as these are related to bone 
strength in community-dwelling older women.
Methods: Participants were older women from the Cohort of Skeletal Health in Bristol and Avon. We defined sarcopenia using the EWGSOP 
criteria. Lower limb peak muscle power and force were assessed using Jumping Mechanography (JM). High vertical impacts were assessed 
by tri-axial accelerometry (at least 1.5g above gravity). Cross-sectional associations were analyzed by linear regression, adjusting for age, 
height and weight (or fat mass for models including appendicular lean mass index), comorbidities, smoking, alcohol, and Index of Multiple 
Deprivation.
Results: Our analyses included 380 participants, with mean age 76.7 (SD 3.0) years; 242 (64%) also completed JM. In age-adjusted analysis, 
a negative relationship was observed between severity of sarcopenia and high, but not medium or low, impacts (p = .03 for trend). Regarding 
components of sarcopenia underlying this relationship, multivariable analyses revealed that gait speed (β 1.47 [95% CI 1.14, 1.89], [β-1] 
reflects the proportionate increase in high impacts per SD increase in exposure) and peak force (1.40 [1.07, 1.84]) were independently 
associated with high impacts.
Conclusions: Older women with sarcopenia experienced fewer bone-strengthening high impacts than those with presarcopenia or without 
sarcopenia. To increase bone strengthening activity in older women, interventions need to improve both lower limb muscle force and walking 
speed.
Keywords: Muscle function, Physical capability, Accelerometer, G-force, COSHIBA
Sarcopenia, a common disorder of older age, is associated with 
increased mortality (1) and constitutes a significant economic bur-
den (2). The European Working Group on Sarcopenia in Older 
People (EWGSOP) defines sarcopenia as low Appendicular Lean 
Mass Index (ALMI) plus low muscle strength and/or low physical 
performance (3). Additional categories comprise presarcopenia (low 
ALMI only), and severe sarcopenia (low ALMI, muscle strength, and 
performance). Prevalence estimates for sarcopenia vary depending 
upon the definition, with recent estimates suggesting up to 29% of 
community-dwelling older adults are sarcopenic (4). Frailty, one of 
the main clinical manifestations of sarcopenia, partly reflects the 
functional consequences of impaired muscle strength on physical 
performance. For example, the widely used short physical perform-
ance battery (SPPB, based on gait speed, chair-rise time, and balance 
(5)) can be used to identify individuals with sarcopenia and frailty 
(3,6).
Sarcopenia has been associated with reduced PA; sarcopenic 
adults (defined using EWGSOP criteria) participated in less mod-
erate-vigorous PA (MVPA) than nonsarcopenic adults in a recent 
large population-based analysis (7). Longitudinal studies suggest 
being more active may prevent age-related loss of lean mass (8,9). 
Conversely, recent longitudinal analyses from UK Biobank identified 
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a positive relationship between baseline grip strength and PA at 
follow-up (10), suggesting that better muscle function also predicts 
ability to undertake PA. Further evidence exists supporting a cross-
sectional association between physical activity (PA) and physical 
performance (11–14).
Interest is growing regarding the influence of vertical impacts 
achieved during habitual PA, particularly on Bone Mineral Density 
(BMD), since historic animal studies first highlighted the relation-
ship between mechanical strain and bone formation (15). A meta-
analysis of intervention studies for postmenopausal women found 
that interventions including high impact PA (eg, jogging), combined 
with walking and stair climbing, were most beneficial at preserving 
hip and lumbar spine BMD (16). Moreover, a hopping intervention 
successfully increased BMD of the femoral neck in older men (17). 
Furthermore, we recently determined that exposure to high impacts 
(at least 1.5g above gravity), ascertained by 7-day accelerometry, 
was associated with hip strength in community-dwelling older 
women (18).
Although sarcopenia has been associated with lower general-
ized PA (7), the extent to which PA of differing impacts is specif-
ically reduced has not been evaluated. As high impact PA places 
a greater demand on muscle function, we hypothesized that sar-
copenia would be strongly associated with reduced high impacts. 
Therefore, we aimed to determine the relationship between sar-
copenia and habitual levels of PA, categorized according to levels 
of vertical impact, in a population of community-dwelling older 
women. Furthermore, we examined associations between different 
components of muscle size, function, and physical performance and 
vertical impacts, including lower limb muscle force, which we hy-
pothesize to be particularly strongly related to high levels of vertical 
impacts.
Methods
Study Population
Participants were recruited from the Cohort of Skeletal Health in 
Bristol and Avon (COSHIBA), comprising women recruited during 
2007–2009 through general practitioner registries within Southwest 
England, born between January 1, 1927 and December 31, 1942 
(19). Four hundred and sixty-three women were recruited 5–7 years 
from baseline (14% of baseline), who attended our research clinic 
for musculoskeletal and physical function assessments during 2015 
(Figure 1). A detailed explanation of all assessments was provided 
and full written consent obtained. Participants completed a study 
questionnaire after functional assessment, collecting demographic, 
health, and lifestyle data. The study was approved by the South 
West: Frenchay Research Ethics Committee (14/SW/0138).
Exposures
Jumping mechanography (JM)
Muscle power and force were assessed using a Leonardo 
Mechanography Ground Reaction Force platform. The platform 
consists of two plates with corner sensors which detect voltage pro-
portional to applied force (20). Sensor recordings are used to de-
rive test-specific performance calculations using Leonardo software 
(version 4.2, Novotec Medical, Germany). All participants with a 
SPPB (see next methods section) score ≥6 were eligible (ie, physically 
capable and safe to jump). Peak power was assessed by two-legged 
jump and peak force by one-legged hopping. Additional information 
is provided in the Supplementary Material.
SPPB
SPPB comprises tests of balance (side-by-side, semitandem, and tandem 
balances performed for up to a maximum of 10 seconds), chair rise time 
(five timed chair rises as fast as possible [without using arms]), and gait 
speed (4-m timed walk at usual speed, best of two scored), each test 
being scored out of four points giving a maximal total score of 12 (5).
Dual x-ray absorptiometry (DXA) and anthropometric 
measures
All consenting participants underwent DXA scanning of the total 
body to measure lean mass (LM) and fat mass (FM); the meth-
odology has previously been described (18) (see Supplementary 
Material). Before DXA scanning, height was measured using a 
Harpenden stadiometer (Holtain Ltd., Crymych, UK), to the near-
est millimetre. Weight was measured using Tanita scales (Tanita UK 
Ltd., Uxbridge, UK), to the nearest 0.5 kg. ALMI was calculated as 
(total LM arms + total LM legs)/height2.
Peripheral quantitative computed tomography (pQCT) 
measured muscle size
The methodology for pQCT acquisition is described elsewhere (18) 
(see Supplementary Material). Muscle cross-sectional area (mCSA), 
Sub-population with pQCT and 
JM data
n=242
n=9: missing pQCT data
n=15: not eligible for JM (SPPB<6)
n=45: did not consent to JM
n=64: equipment failure or did not 
complete both jump and hop 
n=5: excluded due to data errors
n=7: outside Bristol/ Bath area
n=222: not invited (at random) due 
to study constraints (all clinic 
spaces filled)
n=20: missing exposure data
n=44: missing covariate data
n=19: missing outcome data
n=1907: did not consent to further 
contact
Original COSHIBA population
n=3200
(2007-2009)
Consented to further contact
n=1293 
(2014)
Attended research clinic
n=463
(2015)
Study population
n=380
n=415: declined
n=128: did not respond
n=58: agreed to participate but did 
not attend clinic
Invited to research clinic
n=1064
(2015)
Figure  1. Flowchart of participant recruitment process and selection of 
study population. COSHIBA = Cohort of Skeletal Health in Bristol and Avon; 
pQCT  =  Peripheral Quantitative Computed Tomography; JM  =  Jumping 
Mechanography.
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measured at 50% of tibial length, was derived as the total limb cross-
sectional area with density ≥50 mg/cm3 minus total bone content, 
applied filters derived smoothed total mCSA.
Upper limb grip strength
Grip strength was assessed using a JAMAR digital handgrip dyna-
mometer (Patterson Medical, IL), with the handle set at the second 
point. Three tests were performed on each hand (with 30 seconds 
rest between each test) with the participant standing upright (unless 
unable to stand) with their arm fully extended next to their body 
and a stiff wrist. The participant was instructed to squeeze as 
hard as they can for as long as they can, using standard instruc-
tions. Measurements alternated between each hand with a total of 
three attempts for each hand and the maximal value was taken. 
Measurements were recorded to the nearest 0.1 kg.
PA outcomes
The protocol for PA monitoring, and derivation of impact vari-
ables, has been described elsewhere (21). Briefly, participants were 
given a Gulf Coast Data Concepts x16-1c tri-axial accelerometer 
(Waveland, MS) to wear in a custom-made size-specific elastic belt 
over their right hip during all waking hours (excluding swimming 
and washing) for 7 days. The accelerometers were configured prior 
to each use with a sampling frequency of 50 Hz, a deadband setting 
of 0.1 g (threshold to be exceeded for a recording to be made) and a 
timeout setting of 10 seconds (time of inactivity before the monitor 
turned itself off to conserve battery life). A timesheet was provided 
for the participant to record the time they wore the monitor each 
day, as well as any comments (eg, monitor removed at x time for 
swimming). Data was uploaded and imported into Stata (StataCorp, 
TX) and processed using custom-designed code which cleaned data 
to remove artifacts (eg, monitor falling out of belt) and nonwear 
time. A  valid day was defined as at least 10 hours of wear time. 
A peak was identified as any vertical acceleration greater than the 
previous or subsequent recorded acceleration. Peaks were classified 
into three impact bands: low (0.5≤g<1.0), medium (1.0≤g<1.5), and 
high (≥1.5 g), over and above Earth’s gravity. The number of counts 
in each impact band were normalized to 7 days of 14 hours.
Statistical Analysis
Presarcopenia was defined as low muscle mass (ALMI ≤ 5.45 kg/m2), 
sarcopenia as low muscle mass and low grip strength (<20 kg) or 
gait speed (<0.8 m/s), and severe sarcopenia as low muscle mass, grip 
strength, and gait speed (3). Due to small numbers in the severe sar-
copenia category, sarcopenia and severe sarcopenia were combined 
for analyses.
Descriptive statistics are presented as counts and percentages 
for categorical variables, and mean (standard deviation [SD]) for 
continuous variables, except for accelerometry counts which were 
positively skewed and are presented as median (interquartile range 
[IQR]), and log-transformed.
Relationships between sarcopenia/individual components of 
muscle size and function, and accelerometry counts (number of ver-
tical accelerations) in each PA impact band, were examined using 
linear regression. We adjusted for the following a priori confound-
ers: age at clinic session (model 1); model 1 plus height and weight 
(except for sarcopenia based on ALMI when total body FM was 
included instead of height and weight) (model 2); model two plus 
Index of Multiple Deprivation (IMD), smoking, alcohol consump-
tion (0, >0–<10 or ≥10 units), and comorbidities (0, 1 or ≥2) (model 
3). Methods regarding acquisition of covariates are described in full 
in the Supplementary Material. To identify independent determinants 
of accelerometry counts, muscle function variables were included in 
the same multivariable model, and model fit subsequently evaluated 
(r2 values and Akaike’s Information Criterion [AIC]). All continuous 
exposure variables were standardized. As outcome variables were 
log-transformed, coefficients represent the percentage change in out-
come per SD change in exposure, and percentage difference in geo-
metric mean for categorical variables. Data analysis was performed 
using Stata version 13 (StataCorp, TX). Sensitivity analyses are 
described in the Supplementary Material.
Results
Participant Characteristics
One thousand sixty-four members of the COSHIBA population 
were invited to reattend of whom 380 (36%) provided complete 
data for SPPB, sarcopenia exposures, covariates, and PA outcomes 
and formed the study population (Figure 1). Compared to the base-
line COSHIBA population, those included in the present analysis 
were younger, taller, had a lower BMI and were more highly edu-
cated (Supplementary Table 1).
The mean age of those included in the present study was 76.7 
(3.0) and the mean BMI 27.0 (4.6) kg/m2 (Table 1). 6.3% were clas-
sified as presarcopenic, 3.7% as sarcopenic, and 1.8% as severely 
sarcopenic. The population experienced a median of 8,838 (IQR 
4,333, 16,934) low impacts, 345.3 (109.2, 742.5) medium impacts, 
and 41.8 (17.2, 105.9) high impacts over 1 week. The subgroup who 
underwent JM had a mean age of 76.4 (2.6), mean BMI 26.0 (3.8) 
kg/m2 and 7.4%, 4.1%, and 0.8% were categorized as presarco-
penic, sarcopenic, and severely sarcopenic, respectively.
Clinical Sarcopenia Versus Accelerometry 
Impact Counts
Sarcopenia status was unrelated to low or medium impacts; however, 
sarcopenia status was inversely associated with high impacts in our 
age-adjusted analyses, with lower levels seen in sarcopenia, whereas 
little difference was observed in presarcopenia (p for trend =  .03; 
Figure 2). Decreased physical performance, as indicated by a lower 
SPPB score, was inversely associated with low, medium, and higher 
impacts, primarily reflecting decreased PA levels in those with signifi-
cant physical frailty (SPPB score <6) (all p < .01).
In analyses examining differences in impact counts between those 
above and below the grip strength, gait speed and ALMI thresholds 
for defining sarcopenia, grip strength below 20 kg and gait speed 
slower than 0.8 m/s were associated with fewer low, medium, and 
high impacts over 1 week in all models (all p < .05), including our 
fully-adjusted model (model 3)  (Supplementary Table  2). ALMI 
≤5.45 kg/m2 was associated with approximately a 50% reduction in 
high impacts in models 2 and 3, but was not associated with low or 
medium impact counts in any model. Similar associations between 
low grip strength, gait speed and ALMI and impact counts were 
observed after additional adjustment for calcium/vitamin D supple-
mentation (data not shown).
Individual Components of Muscle Size/Function 
Versus Accelerometry Impact Counts
When gait speed was included as a continuous variable, similar asso-
ciations were observed, with positive associations for all three im-
pact categories and models (Table 2). Chair rise time was inversely 
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related to low and medium impacts in all three models, but there was 
weaker evidence for an association with high impacts. Grip strength 
was positively related to low and medium impacts in models 2 and 3 
and with high impacts in model 3. Peak force was positively related 
to low, medium, and high impacts in model 2 and 3. Peak power 
was positively related to low impacts (model 2 only), and to medium 
impacts (models 2 and 3), whereas no association was seen with 
high impacts. Tandem balance and mCSA were unrelated to impacts.
Multivariable linear regression analyses were performed with all 
predictor variables, based on model 3, to determine which meas-
ures of muscle size and function were independently associated with 
impacts. Gait speed was the only measure associated with low and 
medium impacts (1.26 [1.08, 1.48] and 1.68 [1.33, 2.12], respect-
ively) (Table 3), whereas, gait speed and peak force were both inde-
pendently associated with high impacts (1.47 [1.14, 1.89] and 1.40 
[1.07, 1.84], respectively). Additional adjustment for calcium/vita-
min D supplementation did not attenuate these relationships (data 
not shown). Together, a priori confounders (age, height, weight, 
IMD, comorbidities, smoking, and alcohol) explained 9% of the 
variance in high impacts, gait speed an additional 7%, and peak 
force an additional 4% (Supplementary Table 3). The high impact 
model comprising covariates, gait speed, and peak force had the best 
fit based on AIC, and explained the largest amount of total variance 
(r2 = 0.18).
Discussion
We investigated relationships between sarcopenia and habitual 
levels of PA, categorized according to level of vertical impact, in a 
community-based population of older women. We found that sar-
copenia, defined using EWGSOP criteria, was associated with fewer 
high, but not low or medium, vertical impacts. In contrast, physical 
capability, as reflected by SPPB score, was related to low, medium, 
and high impacts. To clarify these relationships, we examined 
Table 1. Descriptive Characteristics of the Study Population and JM Subpopulation
Overall Study Population (n = 380) Subgroup Having JM (n = 242)
Mean (SD) Mean (SD)
Age 76.7 (3.0) 76.4 (2.6)
Alcohol (units in past week)a 5.4 (7.4) 6.3 (7.5)
IMD Rank 19,734 (8,970) 20,340 (8,872)
BMI (kg/m2) 27.0 (4.6) 26.0 (3.8)
TBFM (kg) 27.9 (8.4) 26.4 (7.3)
SPPB scoreb 10.0 (2.0) 10.7 (1.3)
Gait speed (m/s) 1.0 (0.2) 1.1 (0.2)
Chair rise time (s) 13.6 (5.0) 12.9 (4.2)
ALMI (kg/m2) 6.5 (1.0) 6.3 (0.8)
mCSA (mm2) 4,058.4 (855.8)
Peak power (kW) 1.4 (0.3)
Peak force (kN) 1.3 (0.2)
Grip strength (kg) 21.1 (5.1) 21.8 (4.9)
Median (IQR) Median (IQR)
Physical activity Low impact countsc 8,837.9 (4,332.9, 16,934.4) 11,457.8 (5,779.1, 18,827.9)
Medium impact countsc 345.3 (109.2, 742.5) 452.6 (183.7, 950.9)
High impact countsc 41.8 (17.2, 105.9) 51.8 (23.0, 124.2)
N (%) N (%)
Ethnicity White Britisha 368 (96.8) 237 (97.9)
Comorbidities 0 148 (39.0) 111 (45.9)
1 173 (45.5) 107 (44.2)
≥2 59 (15.5) 24 (9.9)
Smokera Never 231 (60.8) 152 (62.8)
Current 4 (1.1) 3 (1.2)
Past 145 (38.2) 87 (36.0)
Calcium/Vitamin D supplementsa 142 (37.4) 76 (31.4)
Tandem balance Held < 10 s 84 (22.1) 29 (12.0)
Sarcopeniad None 335 (88.2) 212 (87.6)
Presarcopenia 24 (6.3) 18 (7.4)
Sarcopenia 14 (3.7) 10 (4.1)
Severe 7 (1.8) 2 (0.8)
Note: ALMI = Appendicular lean mass index; BMI = Body mass index; IMD = Index of multiple deprivation; IQR = Interquartile range; mCSA = Muscle 
cross-sectional area; SD = Standard deviation; TBFM = Total body fat mass.
aSelf-reported in study questionnaire. bSPPB = Short physical performance battery. Score out of 12 based on a maximum of four for each of component: balance, 
chair rise and gait speed. cLow impacts 0.5≤0.5 g<1.0 g, medium impacts 1.0≤g<1.5, high impacts ≥1.5 g. dPresarcopenia defined as ALMI ≤5.45 kg/m2. Sarcopenia 
defined as ALMI ≤5.45 kg/m2 plus either grip strength <20 kg or gait speed <0.8 m/s. Severe sarcopenia defined as ALMI ≤5.45 kg/m2, gait speed<0.8 m/s, and 
grip strength <20 kg.
Mean height and weight of overall population: 158.9 (6.1) cm, 68.2 (11.9) kg and of subpopulation: 159.7 (6.1) cm, 66.3 (10.2) kg.
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associations between individual components of sarcopenia and ver-
tical impacts, with a focus on lower limb muscle function. Gait speed 
was independently associated with low, medium, and high impacts; 
peak lower limb muscle force was independently associated with 
high impacts only. Our results are broadly consistent with previous 
reports that sarcopenic individuals participated in less MVPA (7). 
However, we extend this by establishing relationships between sar-
copenia and high impacts specifically.
There is significant overlap in the definitions of sarcopenia and 
physical frailty—gait speed and grip strength assessment can be used 
to identify both conditions (22,23). Our observation that gait speed 
and grip strength were associated with low, medium, and high ver-
tical impacts suggests that physical frailty is associated with reduced 
activity across all impacts, whereas our sarcopenia measure was 
only associated with high impacts. This suggests that other factors, 
related to muscle quality, may contribute to high impact activity. 
When patients with cardio-respiratory disease were excluded, gait 
speed was no longer related to high impacts, whereas a stronger as-
sociation was observed with muscle force. A possible explanation 
being that patients with cardio-respiratory disease avoid high im-
pact activity for reasons unrelated to sarcopenia, and their exclusion 
uncovers stronger underlying determinants of high impacts acting 
through sarcopenia.
Our finding that grip strength and gait speed were associated 
with reduced vertical impacts in all categories is consistent with 
previous studies. A longitudinal analysis identified grip strength to 
be associated with MVPA in men and women aged 60+ (10). In 
older men, gait speed and grip strength have been associated with 
MVPA (24). A recent longitudinal analysis identified gait speed to 
be predictive of change in amount of walking, independent of grip 
strength (25). In the present study, an independent influence of gait 
speed was observed, but not grip strength. Our finding that low 
ALMI was associated with reduced high impacts specifically, whilst 
muscle function was associated with reduced counts in all impact 
bands is consistent with the work of Rojer et al., who found an asso-
ciation between objectively-measured total daily PA and gait speed, 
but not muscle mass, in older adults (26).
High impacts have previously been associated with bone strength 
in our study population (18). Hence, increasing participation in 
higher impact activities, such as aerobics classes, may represent an 
effective means of improving bone strength and reducing fracture 
risk (27). Our findings suggest that in order to be successful, inter-
ventions need to address intrinsic factors which determine ability 
to generate high impacts, such as lower limb peak muscle force. In 
support of this conclusion, a previous meta-analysis found high im-
pact PA alone was not effective at maintaining BMD at the hip or 
lumbar spine; other activity types, such as resistance training are 
required in combination with high impact activity to maintain BMD 
in postmenopausal women (16). Zhao et al. also found that a com-
bination of resistance training and high impact or weight-bearing 
exercise increased BMD of the femoral neck and lower spine (28). 
The benefit of resistance training to improve muscle mass, strength, 
and physical performance is well established (4,29–31). As well as 
increasing bone strength, our findings may also reflect a positive 
impact of higher impact PA on sarcopenia and mobility. Hence, 
interventions designed to improve mobility and delay the onset of 
sarcopenia in older people may also benefit from inclusion of higher 
impact activities.
Figure 2. Plot of age-adjusted mean log-transformed impact counts by sarcopenia category and SPPB category. Points represent beta coefficients from linear 
regression adjusted for age. Bars represent 95% confidence intervals. Presarcopenia defined as ALMI ≤5.45 kg/m2. Sarcopenia defined as ALMI ≤5.45 kg/m2 plus 
either grip strength <20 kg and/or gait speed <0.8 m/s. ALMI = Appendicular Lean Mass Index; SPPB = Short Physical Performance Battery. Score out of 12 based 
on a maximum of four points for each of the three components: balance, chair rise, and gait speed. Low impacts 0.5<0.5g<1.0g, medium impacts 1.0<g<1.5, high 
impacts≥1.5g.
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Strengths and Limitations
The strengths of this study include the objective measurement of high 
impact PA by accelerometers. In addition, data were available for a 
wide range of variables allowing adjustment for a priori confound-
ers. The availability of JM-derived variables as additional measures 
of lower limb muscle function is another strength.
The study populations were younger and more highly educated 
than the source population, which limits generalizability of our 
results to all community-dwelling older women. The population is 
female only; the relationship between sarcopenia and high impact 
PA has yet to be investigated in older men. Restricting JM analysis 
to those participants scoring ≥6 on SPPB meant we were unable 
to analyze the relationship between muscle function measures and 
high impact activity in participants with low physical function. This 
study is cross-sectional and therefore a causal relationship between 
low muscle function and high impact counts cannot be inferred; it is 
Table 3. Multivariable Linear Regression Analyses Showing the Relationships Between Measures of Muscle Mass and Function and Low, 
Medium, and High Impact Accelerometry Counts
Low Medium High
β (95% CI) p β (95% CI) p β (95% CI) p
Gait speed 1.26 (1.08, 1.48) <.01 1.68 (1.33, 2.12) <.01 1.47 (1.14, 1.89) <.01
Chair stand time 1.00 (0.87, 1.16) .99 0.95 (0.77, 1.18) .64 1.03 (0.82, 1.30) .78
Tandem balance <10 sa 1.05 (0.75, 1.47) .79 1.01 (0.62, 1.66) .95 1.05 (0.61, 1.79) .86
Grip strength 1.10 (0.96, 1.25) .17 1.08 (0.89, 1.31) .42 1.14 (0.92, 1.40) .22
Peak force 1.17 (0.99, 1.39) .07 1.23 (0.95, 1.57) .11 1.40 (1.07, 1.84) .02
Peak power 1.01 (0.84, 1.22) .90 1.10 (0.84, 1.44) .50 0.93 (0.69, 1.26) .64
mCSA 0.95 (0.84, 1.08) .42 0.96 (0.80, 1.15) .64 1.01 (0.82, 1.23) .94
Note: Exponentiated coefficients are presented representing the change in low, medium or high impact counts for an SD increase in muscle function or size 
exposure (eg, a coefficient of 1.24 represents a 24% increase in low impact counts for a 1 SD increase in gait speed). Adjusted for age, height, weight, smoking, 
alcohol, IMD, and comorbidities. N = 242.
CI = Confidence interval; mCSA = Muscle cross-sectional area.
aCoefficient represents the ratio of geometric means with tandem balance 10 s as the reference category.
Low impacts 0.5≤0.5 g<1.0 g, medium impacts 1.0≤g<1.5, high impacts ≥1.5 g
Table 2. Regression Analyses Showing the Relationships Between Measures of Muscle Function or Mass and Low, Medium, and High 
Impact Accelerometry Counts
Model 1 Model 2 Model 3
β (95% CI) p β (95% CI) p β (95% CI) p
Low Gait speed 1.43 (1.25, 1.63) <.01 1.33 (1.17, 1.52) <.01 1.31 (1.14, 1.50) <.01
Chair stand time 0.80 (0.70, 0.91) <.01 0.85 (0.75, 0.96) <.01 0.87 (0.76, 0.99) .04
Tandem balance <10 sa 0.76 (0.54, 1.08) .12 0.82 (0.59, 1.14) .24 0.89 (0.63, 1.24) .48
Grip strength 1.09 (0.97, 1.23) .14 1.14 (1.01, 1.28) .04 1.15 (1.02, 1.30) .03
Peak Force 1.05 (0.90, 1.22) .53 1.30 (1.11, 1.52) <.01 1.25 (1.06, 1.47) <.01
Peak Power 0.97 (0.83, 1.13) .71 1.18 (1.00, 1.39) .04 1.15 (0.98, 1.36) .09
mCSA 0.92 (0.82, 1.03) .15 1.02 (0.91, 1.15) .74 1.02 (0.91, 1.15) .73
Medium Gait speed 1.93 (1.60, 2.33) <.01 1.84 (1.52, 2.22) <.01 1.83 (1.50, 2.22) <.01
Chair stand time 0.69 (0.57, 0.83) <.01 0.72 (0.60, 0.87) <.01 0.73 (0.60, 0.89) <.01
Tandem balance <10 sa 0.65 (0.40, 1.08) .10 0.69 (0.42, 1.14) .15 0.73 (0.44, 1.21) .21
Grip strength 1.15 (0.97, 1.37) .11 1.21 (1.01, 1.45) .03 1.25 (1.04, 1.51) .02
Peak Force 1.18 (0.95, 1.47) .14 1.51 (1.19, 1.92) <.01 1.44 (1.12, 1.84) <.01
Peak Power 1.14 (0.91, 1.42) .26 1.46 (1.14, 1.86) <.01 1.42 (1.11, 1.82) <.01
mCSA 1.01 (0.85, 1.20) .92 1.13 (0.95, 1.35) .17 1.13 (0.94, 1.35) .19
High Gait speed 1.53 (1.25, 1.87) <.01 1.51 (1.22, 1.86) <.01 1.56 (1.26, 1.94) <.01
Chair stand time 0.83 (0.68, 1.00) .06 0.84 (0.69, 1.03) .10 0.83 (0.67, 1.02) .07
Tandem balance <10 sa 0.83 (0.49, 1.39) .47 0.85 (0.50, 1.43) .54 0.82 (0.48, 1.40) .46
Grip strength 1.14 (0.95, 1.36) .16 1.18 (0.97, 1.42) .09 1.22 (1.01, 1.49) .04
Peak Force 1.26 (1.00, 1.57) .05 1.46 (1.14, 1.88) <.01 1.50 (1.15, 1.95) <.01
Peak Power 1.08 (0.86, 1.36) .49 1.22 (0.94, 1.58) .13 1.22 (0.93, 1.59) .15
mCSA 1.05 (0.88, 1.25) .56 1.12 (0.93, 1.34) .25 1.11 (0.92, 1.34) .29
Note: Coefficients represent the change in low, medium or high impact counts for an SD increase in muscle function or size exposure (ie, a coefficient of 1.43 
represents a 43% increase in low impact counts for a 1 SD increase in gait speed). Model 1: adjusted for age; Model 2: adjusted for age, height and weight; Model 
3: adjusted for age, height, weight, smoking, alcohol, Index of Multiple Deprivation, and comorbidities. N = 242. CI = Confidence interval; mCSA = Muscle 
cross-sectional area.
aCoefficient represents the ratio of geometric means with tandem balance 10 s as the reference category.
Low impacts 0.5≤0.5 g<1.0 g, medium impacts 1.0≤g<1.5, high impacts≥1.5 g.
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plausible that lack of high impact PA led to declines in muscle mass 
and function. We used the EWGSOP criteria to define sarcopenia as 
this is the most widely used criteria. However, a recent study of the 
performance of sarcopenia definitions found that the EWGSOP def-
inition was worse at predicting physical and health-related outcomes 
(such as falls risk) compared to a simple strength test (32). The 
EWGSOP thresholds used are arbitrary. Finally, we used a threshold 
of 1.5 g to define high impact activity, due to the rarity of counts 
above this threshold (21); however, this is substantially lower than 
the 3.9 g threshold suggested to be beneficial to bone in premeno-
pausal women (33).
Conclusions
We investigated relationships between sarcopenia and habitual 
levels of PA categorized according to level of vertical impact, in 
a community-based population of older women. We found that 
gait speed and lower limb peak muscle force were independently 
associated with the number of high, potentially osteogenic, impacts 
during everyday activity. These findings underlie the importance of 
including exercises to increase gait speed and lower limb muscle 
force (such as resistance exercises) in PA interventions, intended to 
prevent osteoporosis through greater participation in high impact 
activities.
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Supplementary data is available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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